Search

Home > GRACEcast Lung Cancer Video > ASCO 2012 LC Highlights: Dr. Joel Neal on the MEK Inhibitor Selumetinib in KRAS Mutation-Positive NSCLC (video)
Podcast: GRACEcast Lung Cancer Video
Episode:

ASCO 2012 LC Highlights: Dr. Joel Neal on the MEK Inhibitor Selumetinib in KRAS Mutation-Positive NSCLC (video)
Category: Science & Medicine
Duration: 00:05:11
Publish Date: 2012-09-11 03:57:34
Description:

Dr. Joel Neal reviews the favorable results with chemo combined with the novel targeted therapy selumetinib, a MEK inhibitor, in KRAS mutatino-positive patients with advanced non-small cell lung cancer (NSCLC).
Total Play: 0